Mode
Text Size
Log in / Sign up
N/A N=300 Randomized Supportive Care

Collaborative Connected Health (CCH) for PCORI

Psoriasis

Enrolled (actual)
300
Serious AEs
9.1%
Results posted
Aug 2019
Primary outcome: Primary: Improvement in Self-Administered Psoriasis Area and Severity Index (SA-PASI) — -0.82; -1.37 Score on a Scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Collaborative Connected health, (CCH) (Other); Control (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Southern California
Primary completion
Aug 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Improvement in Self-Administered Psoriasis Area and Severity Index (SA-PASI)
-0.82; -1.37
SECONDARY
Improvement in Quality of Life as Measured by Dermatology-Specific, Quality of Life Instruments
-2.63; -1.79; -1.18; -1.64
SECONDARY
Access to Care: Distance Traveled
178.8; 2.2
SECONDARY
Depression Severity
-0.76; -0.4
SECONDARY
Other Psoriasis Disease Severity Measures
-1.55; -3.38; -.22; -.37
SECONDARY
Access to Care: Wait Time
4.0; 0.1

Summary

The investigators propose to evaluate whether an innovative collaborative connected health (CCH) model increases access to specialists and improves patient outcomes. CCH offers multiple modalities for patients and primary care providers (PCPs) to access dermatologists online directly and asynchronously to maximize effectiveness in a real-world setting. CCH also fosters team care and patient engagement through active sharing of management plans and multidirectional, informed communication among patients, PCPs, and dermatologists. The specific aims of the proposal are to (1) determine whether the CCH model results in equivalent improvements in psoriasis disease severity compared to in-person care, (2) determine whether the CCH model results in equivalent improvements in quality of life and mental health compared to in-person care, and (3) assess whether the CCH model provides better access to care than in-person care.

Eligibility Criteria

Inclusion Criteria

  • Be age 18 years and older
  • Have physician-diagnosed plaque psoriasis
  • Have access to internet and a digital camera or a mobile phone with camera features
  • Have a primary care provider or the ability to establish primary care

Exclusion Criteria

-

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02358135). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search